AST Congratulates New Director Of HRSA Division of Transplantation (DoT)
AST member Dr. Melissa Greenwald has been selected to serve as the new director of the HRSA Division of Transplantation (DoT).
Dr. Greenwald joined HRSA/HSB approximately two years ago and served as a Medical Officer within DoT. She has served as the Acting Director for the division for the last 8 months.
Prior to joining HSB, she worked for 14 years in FDA's Office of Cellular, Tissue, and Gene Therapies where she was a national expert on tissue donor screening and testing policy, served four years as the Chief of the Human Tissue and Reproduction Branch, and was the product reviewer for all communicable disease assays with a claim for organ donors during her tenure.
Dr. Greenwald’s new position is effective July 5, 2016.
Congratulations, Dr. Greenwald!